
---
title: 'WHO HPV实验室网络质评 凯普HPV产品连续六次结果符合临床应用'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=4356'
author: 证券时报网
comments: false
date: Sun, 12 Jun 2022 14:36:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=4356'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300639" style="color: #2f67d1;text-decoration: none;" code="300639" target="_blank">凯普生物</a>消息，2021WHO HPV 评测总结报告《Global HPV DNA PP 2021 technical report》出炉，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300639" style="color: #2f67d1;text-decoration: none;" code="300639" target="_blank">凯普生物</a>的HPV37分型、HPV23分型、HPV21分型、HPV12+2产品在多个实验室参与WHO网络测评，检测结果达到100%准确，总体结果在参与测评的产品中成绩名列第一。之前，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300639" style="color: #2f67d1;text-decoration: none;" code="300639" target="_blank">凯普生物</a>HPV检测产品已连续五次参与WHO HPV网络监测评估，结果均符合临床应用水平和实验室能力要求。</p>

                  
</div>
            